What do you think about the use of ASA in secondary prevention of cardioembolic ischemic stroke in some cases (e.g. SPS ref. Semin Thromb Hemost. 2013 Sep;39(6):674-83.) Some guidelines recommend Dabigatran.
Peter Kubisz Clopidogrel has shown greater effectiveness compared to Aspirin alone in secondary prevention. The utilization of P2Y12 inhibitors has led to a significant 19% reduction in the risk of (MI). Consequently, researchers advocate for a shift away from relying solely on aspirin for long-term therapeutic purposes.